A study involving a many-pronged, therapeutic treatment for Alzheimer’s patients shows effective, improved, memory recall within mere months.

A Way to Stop Forgetting?

A single-drug treatment to slow the progression of Alzheimer’s does not exist. A new study, however, recognized that by combining 36 various methods of therapeutic remedies helped the participants regain memory.

The study was conducted by The Buck Institute for Research on Aging along with UCLA Labs for Neurodegenerative Disease Research. There were only 10 participants—yet, each one displayed memory improvement within the first few months. The Alzheimer patients continued their treatment plan and were re-tested up to two years later. The results showed even better results. The findings claim to be the first to suggest memory loss in patients can be reversed, and improvement sustained.

The treatment is unique in that it combines brain stimulation, lifestyle and dietary alterations, and an intake of vitamins, drugs, and other supplements. Sleep optimization is also part of the therapeutic regimen. The culmination of combined therapies is personalized for each person’s unique brain. Surely, that must be one reason why the initial study was limited to 10 participants.

The Proof is in the Alzheimer’s Patient

Study leader Dr. Dale Bredesen pointed out that many other chronic diseases include a comprehensive treatment utilizing different strategies. For example, treating cancer usually requires chemotherapy, radiation, massage, dietary changes, and medications. Alzheimer’s treatment can also benefit from a combination of therapies.

Before beginning the program, all 10 participants had been diagnosed with well-defined mild cognitive impairment, subjective cognitive impairment, or Alzheimer’s. One 69-year old man was in the process of closing his business when he entered the study. He’d had progressive memory loss for almost 11 years. After six months using this treatment, his wife and co-workers attested to his improved memory. After almost two years on the program, his follow-up testing showed tremendous growth in his long-term memory. He’s back at work and even expanding his business.

Other patients who took part in the research, had also been struggling at work. They have all since returned (and with greater performance) after their treatment. If the patient is willing to remain on his or her protocol, successful results abound. Supposedly, however, it was difficult to keep each participant committed, daily, to the many-thronged approach. It requires tremendous determination, along with the help of a caregiver, to stay on track. Perhaps in the next trial that challenge can be addressed as well. For more articles on best health and disease treatment, check out DrDaveCampbell.com